Rekvina Labs Ltd

After a sustained rally of over 42% in the past 15 trading sessions, Rekvina Labs Ltd has surged to a fresh 52-week high of Rs 59.4 on 11 Sep 2026, marking a remarkable ascent from its 52-week low of Rs 6.75. This milestone comes amid a backdrop of broad technical alignment and price momentum that has propelled the stock well above its key moving averages.

After a sustained rally spanning 14 consecutive trading sessions, Rekvina Labs Ltd surged to a fresh 52-week high of Rs 58.24 on 10 Sep 2026, marking a remarkable ascent from its 52-week low of Rs 6.75. This price milestone underscores a powerful momentum shift, driven predominantly by a confluence of bullish technical indicators across multiple timeframes.

Surging to a new 52-week high of Rs 57.1 on 09 Sep 2026, Rekvina Labs Ltd has demonstrated remarkable price momentum, climbing steadily over the past 13 sessions to deliver a 36.86% gain. This rally stands out amid a broadly subdued market backdrop, underscoring the stock’s technical resilience and strong upward trajectory.

After a sustained rally of over 34% in the past 12 trading sessions, Rekvina Labs Ltd has surged to a fresh 52-week high of Rs 55.99 on 8 Sep 2026, marking a remarkable ascent from its low of Rs 6.75 in the previous year. This milestone is underscored by a confluence of bullish technical indicators and strong price momentum that have propelled the stock well above its key moving averages.

Surging past its previous peaks, Rekvina Labs Ltd reached a fresh 52-week high of Rs 54.9 on 7 Sep 2026, marking a remarkable rally from its 52-week low of Rs 6.75. This breakout is underpinned by a confluence of bullish technical indicators and sustained price momentum, setting the stage for a notable shift in market dynamics despite a broadly subdued Sensex environment.

Rekvina Labs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Surging to a new 52-week high of Rs 53.83 on 4 Sep 2026, Rekvina Labs Ltd has demonstrated remarkable price momentum, rallying over 29% in the past 10 trading sessions. This breakout comes amid a broader market environment where the Sensex trades cautiously below its 50-day moving average, underscoring the stock’s standout technical performance.

Surging to a fresh 52-week high of Rs 52.78 on 3 Sep 2026, Rekvina Labs Ltd has demonstrated remarkable price momentum, extending gains for nine consecutive sessions and outperforming its sector by 2.13% today. This rally has propelled the stock well above all key moving averages, signalling robust technical strength.

With a sustained rally over eight consecutive sessions, Rekvina Labs Ltd surged to a fresh 52-week high of Rs 51.75 on 2 Sep 2026, marking a remarkable turnaround from its 52-week low of Rs 6.75. This price milestone is underpinned by a confluence of bullish technical indicators and robust price momentum, even as the broader market struggles with a three-week decline.

Surging past Rs 50.74 on 1 Sep 2026, Rekvina Labs Ltd has reached a new 52-week high, propelled by a sustained seven-day rally that has delivered a remarkable 21.62% gain. This milestone caps a year-long journey from a low of Rs 6.75, underscoring a powerful momentum shift in the stock’s technical profile.

Surging past its previous peaks, Rekvina Labs Ltd touched a fresh 52-week high of Rs 49.75 on 31 Aug 2026, propelled by a sustained six-day rally that has delivered a remarkable 19.25% gain. This price milestone comes amid a broader market backdrop where the Sensex has been under pressure, highlighting the stock’s distinctive momentum.

Rekvina Labs Ltd reached a significant milestone on 28 Aug 2026, touching a new 52-week high of Rs.48.78. This achievement marks a notable phase of momentum for the stock, which has demonstrated consistent gains over the past week, outperforming its sector and trading well above key moving averages.

With a decisive break above Rs 47.83 on 27 Aug 2026, Rekvina Labs Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions.

With a decisive break above Rs 46.85 on 26 Aug 2026, Rekvina Labs Ltd has reached a new 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions.

Rekvina Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 19 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Rekvina Labs Limited, a micro-cap pharmaceutical contract manufacturer with a market capitalisation of ₹20.00 crores, reported a net loss of ₹0.06 crores for Q4 FY26 (Mar'26), marking a 50.00% reduction in losses compared to the previous quarter's ₹0.12 crores loss. Whilst the company demonstrated sequential revenue growth of 105.71% to reach ₹0.72 crores in Q4 FY26, the persistent inability to achieve profitability and negative operating margins continue to raise serious concerns about the viability of its business model.